Antibiotic Therapy for Prosthetic Joint Infections: An Overview

Area of Science:

• Orthopedic Surgery
• Infectious Diseases
• Pharmacology

Background:

• Prosthetic joint infection (PJI) is a serious complication following joint replacement surgery.
• Effective PJI management necessitates a combined approach of surgical intervention and prolonged antibiotic therapy.
• Current guidelines exist, but optimal antibiotic strategies for PJI remain incompletely defined.

Purpose of the Study:

• To review and synthesize current literature, guidelines, and expert experience on prosthetic joint infection management.
• To highlight key considerations in antibiotic therapy for PJI, including drug selection and optimization.
• To provide insights into the interplay between surgical strategies and antibiotic efficacy in treating complex bone and joint infections.

Main Methods:

• Literature review of recent data and published guidelines on PJI management.
• Analysis of antibiotic therapy aspects, including pharmacokinetics, pharmacodynamics, and drug combinations.
• Incorporation of clinical experience from a referral center specializing in complex bone and joint infections.

Main Results:

• Antibiotic efficacy in PJI is significantly influenced by the surgical procedure's quality and microbiological diagnosis.
• Key antibiotic considerations include optimal agent selection, pharmacokinetic/pharmacodynamic optimization, route of administration, and monotherapy versus combination regimens.
• Therapeutic drug monitoring and patient education are vital for improving compliance and tolerance.

Conclusions:

• Prosthetic joint infection management is complex, requiring a multidisciplinary approach.
• Optimizing antibiotic therapy, alongside appropriate surgical intervention, is essential for successful PJI treatment.
• Further research and adherence to best practices in antibiotic selection and administration are needed to improve patient outcomes.